March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
- IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
- PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
- NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
- COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
- TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS
(([email protected];;))
- Forums
- ASX - By Stock
- IMU
- News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.7¢ | 5.8¢ | 5.6¢ | $74.67K | 1.315M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 306428 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 852869 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 314301 | 0.057 |
21 | 2465864 | 0.056 |
18 | 4470054 | 0.055 |
28 | 2958154 | 0.054 |
16 | 2705884 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 912869 | 9 |
0.059 | 978106 | 7 |
0.060 | 1777808 | 19 |
0.061 | 3329688 | 14 |
0.062 | 2777833 | 8 |
Last trade - 10.29am 26/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |